Çocuklarda Konvulsiyonun Nadir Bir Nedeni Akut İntermittan Porfiria: Olgu Sunumu
Öz
Anahtar Kelimeler
Kaynakça
- 1. Puy H, Gouya L, Deybach JC. Porphyrias. Lancet, 2010;375:924-937
- 2. Kumar S, Sharma N, Modi M, Sharma A, Mahi S, Varma S. Spectrum of emergency department presentation in patients of acute intermittent porphyria: experiencefrom a North Indiantertiary care center. NeurolIndia, 2010;58(1):95-98.
- 3. Elder G, Harper P, Badminton M, et al. The incidence of inherited prhphyrias in Europe. J InheritMetabDis, 2013;36(5):849-857.
- 4. Gross U, Sassa S, Jacob K, et al. 5-aminolevulinic acid dehydratase deficiency porphyria: a twenty-year clinical and biochemical follow-up. ClinChem, 1998; 44: 1892-1896.
- 5. Tishler PV. The effect of therapeutic drugs and other pharmacologic agents on activity of porphobilinogen deaminase, he enzymethat is deficient in intermittent acute porphyria. Life Sci, 1999; 65: 207-214.
- 6. Chesney RW, Chesney t. Disorders of porphyrin, pürine and pyrimidine metabolism. IN: Burg FD, İngelfinger JR, Wald ER (eds). Gellis and Kagan’s Current Pediatric Therapy (14thed). Philadelphia: WB Saunders, 1993:334-337.
- 7. Fugate J.E., Rabinstein A.A. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015;14(9):914–925.
- 8. Won SC, Kwon SY, Han JW, et al. Posterior reversible encephalopathy syndrome in childhood with hematologic/oncologic diseases. Journal of Pediatric Hematology/Oncology, 2009;31(7):505-508.
Ayrıntılar
Birincil Dil
Türkçe
Konular
Klinik Tıp Bilimleri
Bölüm
Olgu Sunumu
Yazarlar
Arzu Polat
0000-0002-0397-7074
Türkiye
Havva Yazıcı
0000-0002-2564-7420
Türkiye
Özlem Acar
0000-0001-8226-6539
Türkiye
Yayımlanma Tarihi
29 Ekim 2022
Gönderilme Tarihi
24 Ağustos 2021
Kabul Tarihi
11 Şubat 2022
Yayımlandığı Sayı
Yıl 2022 Cilt: 4 Sayı: 3